Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-24 @ 9:07 PM
NCT ID:
NCT02234804
Eligibility Criteria:
Inclusion Criteria:
* Stable or unstable angina pectoris or silent angina pectoris.
* De novo coronary bifurcation lesions at "LAD/diagonal", "Cx/obtuse marginal", "right coronary artery (RCA)- posterior descending artery (PDA)/posterolateral branch" or "left main (LM)/Cx/LAD".
* All Medina classes except Medina 0.0.1.
* Diameter of side branch ≥2.5 mm.
* Diameter stenosis \>50% by operator's visual assessment
* Signed informed consent
Exclusion Criteria:
* ST-elevation infarction within 48 hours.
* Side branch lesion length \>5 mm.
* Expected survival \< 1 year
* Severe heart failure (NYHA≥III)
* S-creatinine \>120 µmol/l.
* Allergy to Contrast media, Aspirin, Clopidogrel, Ticagrelor, Ticlopidine, Everolimus or Zotarolimus.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02234804
Study Brief:
Protocol Section:
NCT02234804